CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | Shea Jacqueline Elizabeth Chief Executive Officer | Exercise or conversion | +28,296 | 123,327 | ||
| 2026-05-20 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −12,306 | $1.23 | $15K | 111,021 |
| 2026-05-20 | Shea Jacqueline Elizabeth Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −28,296 | 56,592 | ||
| 2026-05-20 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Common Stock Option | +123,760 | 123,760 | ||
| 2026-05-20 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Restricted Stock Unit | +100,240 | 100,240 | ||
| 2026-05-15 | Shea Jacqueline Elizabeth Chief Executive Officer | Exercise or conversion | +17,744 | 102,748 | ||
| 2026-05-15 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −7,717 | $1.30 | $10K | 95,031 |
| 2026-05-15 | Shea Jacqueline Elizabeth Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −17,744 | 0 | ||
| 2026-03-04 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Common Stock Option | +97,240 | 97,240 | ||
| 2026-03-04 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Restricted Stock Unit | +78,760 | 78,760 | ||
| 2026-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Exercise or conversion | +18,632 | 78,317 | ||
| 2026-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −8,057 | $1.79 | $14K | 70,260 |
| 2026-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Exercise or conversion | +28,401 | 98,661 | ||
| 2026-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −13,657 | $1.79 | $24K | 85,004 |
| 2026-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −18,632 | 18,631 | ||
| 2026-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −28,401 | 56,800 | ||
| 2025-05-20 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Restricted Stock Unit | +84,888 | 84,888 | ||
| 2025-05-20 | Shea Jacqueline Elizabeth Chief Executive Officer | Grant or award · Common Stock Option | +105,262 | 105,262 | ||
| 2025-05-15 | Shea Jacqueline Elizabeth Chief Executive Officer | Exercise or conversion | +17,744 | 67,402 | ||
| 2025-05-15 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −7,717 | $1.95 | $15K | 59,685 |
Page 1 of 6 · 101 trades